These data translate our in vitro findings into our in vivo model of ErbB2-overexpressing breast cancer by corroborating the anti-proliferative properties of AZD4547 in MMTV-ErbB2 mice and demonstrate the ability of AZD4547 to alter mammary morphogenesis. This evidence concerns the gene ERBB2 and breast carcinoma.